CME and CFTC Engage in a Bitter Dispute Over On-Chain Perpetual Futures

The Commodity Futures Trading Commission's decision to allow the listing of crypto perpetual futures has ignited a fierce battle between the regulator and the CME Group, the largest derivatives exchange operator in the US. The CME has filed a lawsuit against the CFTC, arguing that the products are mislabeled and that the agency's sudden embrace of them did not consider the potential consequences. The CFTC, on the other hand, claims that the products are legitimate and that the CME is trying to stifle competition. The dispute has significant implications for the US approach to the rapidly growing market, with non-US perpetual futures volume reportedly reaching $60 trillion last year. The CME's lawsuit argues that perpetual futures are harmful to its long-dated futures products and that the CFTC's approval of them did not follow proper procedures. The regulator, however, maintains that the products are lawful and that the CME is trying to protect its own interests. The battle between the two entities has been brewing for months, with the CME attempting to fast-track 24/7 trading for crude oil futures, only to be blocked by the CFTC. The regulator's chairman, Mike Selig, has been vocal in his support for the products, while the CME's chairman, Terry Duffy, has expressed concerns about the potential risks and lack of oversight. The dispute has sparked a heated debate over the future of the market, with some arguing that the CME is trying to stifle innovation and others claiming that the regulator is not doing enough to protect investors. As the battle between the CME and the CFTC continues, the future of the US perpetual futures market remains uncertain, with significant implications for the entire financial industry.